FDA Requires New Opioid Label Warnings Over Risks Of Suddenly Stopping Treatment
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
«
»
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
The FDA is putting in place new rules on prescribing fast-acting forms of fentanyl in an effort to prevent overdoses, adverse events and misuse.…
Oklahoma and Purdue Pharma have reached a $270 million settlement to resolve claims the company’s mislead the public about the safety of OxyContin, helping to spur the national opioid crisis.…
A new study finds that long-term opioid prescriptions are increasing, and that prescriptions of the powerful painkillers vary widely from state-to-state.…
Plastic surgery patients are more susceptible to opioid drug addiction, according to the findings of a new study.…
A new study links increased rates of neonatal abstinence syndrome to high unemployment and a lack of access to mental health services, particularly in rural counties.…
A new study finds that more than half of patients prescribed fast-acting fentanyl painkillers shouldn’t have been, according to the strict rules of an FDA program meant to prevent misuse.…
A new study highlights potential links between marketing tactics and opioid overdoses and prescriptions.…
Injecting opioids increases the risk of serious heart infections, according to the findings of a new study.…
A new study finds increasing incidence of women giving birth while using opioids and meth, resulting in worsening health outcomes for both mother and child.…